Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effect of Caenorhabditis elegans U6 Promoters on CRISPR/Cas9-Mediated Gene Editing Efficiency

View through CrossRef
Abstract Objective This study investigated the effects of endogenous C. elegans U6 promoters on dpy-10 gene editing efficiency. Methods We screened endogenous U6 snRNA genes from the WormBase database and constructed 14 editing plasmids targeting dpy-10 by replacing the U6 r07e5.16 promoter in pSX524 (P eft-3 :: cas9::tbb-2 terminator::U6 r07e5.16 :: dpy-10 sgRNA ) through molecular cloning. Following standardized microinjection protocols, we quantified gene editing efficiency and high-efficiency gene editing index based on dpy-10 mutant phenotypes in F1 progeny. Results Fifteen U6 snRNA genes ( r07e5.16, f35c11.9, t20d3.13, k09b11.15, k09b11.16, w05b2.8, c28a5.7, f54c8.9, k09b11.11, k09b11.12, k09b11.14, t20d3.12, f54c8.8, f54c8.10, k09b11.13 ) were identified from WormBase database. Comparative analysis revealed four U6 promoters ( w05b2.8, c28a5.7, f54c8.9 , and k09b11.11 ) significantly enhanced gene editing compared to other U6 promoters, including commonly used U6 r07e5.16 and U6 k09b11.12 promoters in C. elegans community. Notably, the gRNA F+E scaffold showed no improvement over the gRNA scaffold when paired with the optimal U6 w05b2.8 promoter. Conclusion This study identifies superior U6 promoters for C. elegans gene editing and demonstrates the critical role of promoter optimization in CRISPR systems, providing novel insights for technical refinement.
Title: Effect of Caenorhabditis elegans U6 Promoters on CRISPR/Cas9-Mediated Gene Editing Efficiency
Description:
Abstract Objective This study investigated the effects of endogenous C.
elegans U6 promoters on dpy-10 gene editing efficiency.
Methods We screened endogenous U6 snRNA genes from the WormBase database and constructed 14 editing plasmids targeting dpy-10 by replacing the U6 r07e5.
16 promoter in pSX524 (P eft-3 :: cas9::tbb-2 terminator::U6 r07e5.
16 :: dpy-10 sgRNA ) through molecular cloning.
Following standardized microinjection protocols, we quantified gene editing efficiency and high-efficiency gene editing index based on dpy-10 mutant phenotypes in F1 progeny.
Results Fifteen U6 snRNA genes ( r07e5.
16, f35c11.
9, t20d3.
13, k09b11.
15, k09b11.
16, w05b2.
8, c28a5.
7, f54c8.
9, k09b11.
11, k09b11.
12, k09b11.
14, t20d3.
12, f54c8.
8, f54c8.
10, k09b11.
13 ) were identified from WormBase database.
Comparative analysis revealed four U6 promoters ( w05b2.
8, c28a5.
7, f54c8.
9 , and k09b11.
11 ) significantly enhanced gene editing compared to other U6 promoters, including commonly used U6 r07e5.
16 and U6 k09b11.
12 promoters in C.
elegans community.
Notably, the gRNA F+E scaffold showed no improvement over the gRNA scaffold when paired with the optimal U6 w05b2.
8 promoter.
Conclusion This study identifies superior U6 promoters for C.
elegans gene editing and demonstrates the critical role of promoter optimization in CRISPR systems, providing novel insights for technical refinement.

Related Results

Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Since its inception in 2012, the gene editing technology CRISPR-Cas9 has rapidly become a revolutionary tool in the field of gene editing due to its high efficiency, specificity, a...
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...
Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
Breast cancer (BC) is considered as the most frequent cancer among women and a significant contributor to mortality. The CRISPR/Cas9 gene-editing tool has promising applications fo...
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
The degenerative nature of Alzheimer's disease (AD) and its severe effects on cognitive function present a major challenge to worldwide healthcare systems. CRISPR/Cas9, one of the ...
CRISPR therapy: A revolutionary breakthrough in genetic medicine
CRISPR therapy: A revolutionary breakthrough in genetic medicine
Gene editing with CRISPR-Cas9 technology revolutionizes modern medicine by enabling precise DNA modifications. Initially discovered as a bacterial defense mechanism, the Cas9 enzym...
Fundamentals of CRISPR-Cas9: Gene-editing technology and basic
Fundamentals of CRISPR-Cas9: Gene-editing technology and basic
The CRISPR/Cas9 system provides a robust and multiplexable genome editing tool, enabling researchers to precisely manipulate specific genomic elements and facilitating the elucidat...
CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments
CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments
In recent years, clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) protein have emerged as a revolutionary gene editing tool to treat ...

Back to Top